Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 27,402

Document Document Title
WO/2020/059772A1
Provided are: a therapeutic agent for HER3 mutant cancer, the therapeutic agent containing an anti-HER3 antibody-drug conjugate as an active ingredient; and/or a cancer treatment method characterized in that said anti-HER3 antibody-drug ...  
WO/2020/059705A1
Provided is a method for using a STAT3 inhibitor having a high antineoplastic effect and few side effects. An antineoplastic agent obtained by combining a quinoline carboxamide derivative represented by formula (I) (where, R1, R2, R3, R4...  
WO/2020/058553A2
The present invention relates to the field of food-type compositions. Specifically, it relates to a composition comprising at least one milk protein hydrolysate and a Ginkgo biloba extract. It also relates to the use of said composition ...  
WO/2020/054937A1
The present invention can provide a feminine cleanser composition comprising, on the basis of 100 parts by weight of a polar solvent, 0.01 to 0.1 parts by weight of vegetable chitosan, 0.05 to 0.5 parts by weight of an organic acid, and ...  
WO/2020/054782A1
The present invention provides improved accuracy of an index for estimating the efficacy of drug therapy for breast cancer. Specifically, provided is a method for estimating breast cancer cell abundance, the method comprising the followi...  
WO/2020/054813A1
The present invention provides an anti-EpoR peptide having the structure represented by formula (I): X1-SCH(A1)(A2)(A3)(A4)(A5)(A6)V(A7)(A8)-X2 (X1 is the amino terminal side of the peptide; X2 is the carboxy terminal side of the peptide...  
WO/2020/054871A1
The purpose of the present invention is to provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject. The present invention provides a pharmaceutical composition conta...  
WO/2020/051344A1
This invention is directed to selective androgen receptor degrader (SARD) compounds including heterocyclic rings and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant...  
WO/2020/048471A1
Disclosed are a 7-substituted indazole derivative as shown in formula (I) or a pharmaceutically acceptable salt thereof, and a preparation method therefor, and the use of the same as a therapeutic agent, especially as aIRAK4 kinase inhib...  
WO/2020/051362A1
Provided herein are methods of using mesenchymal stem cell (MSC) exosomes to treat placental insufficiency and/or infertility in a female subject, and/or treating fetal growth restriction in a fetus.  
WO/2020/043700A2
A mineral selected from the group consisting of iron, manganese and magnesium, or combination of two of more thereof; An n-3 fatty acid selected from the group consisting of docosahexaenoic acid (DHA) and 18:3 n-3 octadecatrienoic acid (...  
WO/2020/042988A1
A traditional Chinese medicine composition, made from cassia twig, poria, cortex moutan, radix paeoniae alba, peach kernel in equal proportions. The traditional Chinese medicine composition comprises paeoniflorin, amygdalin, benzoylpaeon...  
WO/2020/045646A1
The present invention provides a monoclonal antibody having high selectivity and affinity for AGEs, particularly for glyceraldehyde-derived AGEs or glycolaldehyde-derived AGEs, and an analytical method using the same. The present inventi...  
WO/2020/042653A1
The present invention belongs to the field of antibody medicines and relates to a humanized anti-VEGFR2 single-chain antibody and a use thereof. The single-chain antibody comprises a heavy-chain variable region with a sequence as shown i...  
WO/2020/037853A1
A composition for promoting microcirculation and improving a function of a human body and a preparation method therefor. The composition is made from radix angelicae dahuricae and oyster by extraction and yeast by fermentation, and can t...  
WO/2020/038460A1
Provided by the present invention is a novel quinoline derivative inhibitor, which has a structure represented by the following general formula (I). The compound of the present invention may selectively inhibit the TAM family of tyrosine...  
WO/2020/035115A1
The invention relates to a tampon which comprises at least one active substance to prevent or alleviate dysmenorrhea.  
WO/2020/035019A1
The present invention relates to an indazole derivative as shown in general formula (I) or a pharmaceutically acceptable salt thereof, a preparation method therefor, and the use thereof as a therapeutic agent, especially as an IRAK4 kina...  
WO/2020/032988A1
Pharmaceutical preparations include at least one component that enhances sexual response and at least one other compound that enhances sexual sensitivity and pleasure. The component that enhances sexual response enhances blood flow to th...  
WO/2020/027239A1
The present invention provides an epitope peptide derived from CDCA1 that has the ability to induce cytotoxic T cells. The present invention also provides a polynucleotide encoding the peptide, an antigen-presenting cell presenting the p...  
WO/2020/028630A1
The present invention relates to dosing regimens for GnRH receptor antagonists, and, in particular, dosing regimens for 4-((R)-2-[5-(2- fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzy l)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyr...  
WO/2020/028682A1
The present invention relates to amino acid salts of nicotinic acid and nicotinamide and compositions thereof of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: (I) wherein A, L, M1, M2,...  
WO/2020/027227A1
Disclosed is an oligonucleotide, or a pharmacologically acceptable salt thereof, that contains at least one prescribed nucleoside structure, is capable of binding with a human nSR100 gene, and has activity to suppress the expression of t...  
WO/2020/027318A1
A mucosal vaccine composition for preventing bovine mastitis, which comprises: an antigen originated from Staphylococcus aureus; and a nano gel comprising a polysaccharide having a cationic functional group and a hydrophobic functional g...  
WO/2020/028684A1
The present invention relates to amino acid salts of nicotinic acid and nicotinamide and compositions thereof of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: (I) wherein J, M1, R1, an...  
WO/2020/021509A2
The present invention regards a composition C1 in a form for topical administration comprising beclomethasone or a derivative thereof for use in a method for treating a disease, symptom and/or disorder deriving from an inflammation of th...  
WO/2020/022627A1
According to a skin ointment for treating labia minora skin, provided in the present invention, the skin ointment contains a multi-growth factor as an active ingredient and is periodically applied to the vulva of a user such that the mul...  
WO/2020/023768A1
This document provides methods and materials involved in identifying and treating mammals having a cancer resistant to BET inhibitors. For example, methods and materials for administering (a) one or more AKT inhibitors and/or one or more...  
WO/2020/016210A1
The present invention relates to combinations comprising Calendula officinalis flower oil, Curcuma longa root extract, and Eugenia caryophyllus bud extract, and to their use in the treatment and/or prevention of vulvodynia. The invention...  
WO/2020/013086A1
The present invention relates to a sperm fertility promoter comprising pyrroloquinoline quinone or a salt thereof.  
WO/2020/012315A1
A terpene-enriched composition for treating conditions and/or symptoms associated therewith in a male subject is described, which composition comprises at least one cannabinoid in a specific amount, a primary terpene in a specific amount...  
WO/2020/010919A1
A traditional Chinese medicine composition, a traditional Chinese medicine compound preparation and a preparation method therefor and the use thereof. The traditional Chinese medicine composition and traditional Chinese medicine compound...  
WO/2020/006617A1
The present invention relates to smooth muscle tone modulating synthetic peptides. It also refers to pharmaceutical compositions containing such peptides and to the uses thereof in the treatment of disturbances in which the modulation of...  
WO/2020/006606A1
The present disclosure relates to a pharmaceutical composition in a pharmaceutically acceptable vehicle. The pharmaceutical composition includes a physiologically effective, non-priapismic, dose of a penile-erection-inducing agent or a p...  
WO/2020/008821A1
Provided is a composition to be used in a medicine, food, supplement, or beverage that is capable of treating, preventing, or improving male infertility. This composition for the treatment, prevention, or improvement of male infertility ...  
WO/2020/007780A1
The invention relates to the field of human reproduction, more in particular to situations in which human reproduction is failing. The present invention provides reliable and highly accurate methods for predicting the chance that an assi...  
WO/2020/004568A1
The present invention provides a novel means for promoting equol production in human intestines or a novel means for amelioration of premenstrual syndrome, which is related to such equol production, and for improving skin condition chang...  
WO/2020/006191A1
A natural vaginal care composition is provided. The natural composition includes a biobased vaginal care agent; a biobased thickener; and at least 60% water. The natural composition may optionally include a biobased preservative, a bioba...  
WO/2020/001460A1
Provided are a pharmaceutically acceptable salt, a crystal form of an azabicyclo substituted triazole derivative and a preparation method therefor. In particular, provided are a pharmaceutically acceptable salt, a crystal form of a compo...  
WO/2020/006392A1
Compositions and methods for treating Trichomoniasis using topically administered antibiotics such as aminoglycosides, including streptomycin, spectinomycin, kanamycin A, amikacin, tobramycin, dibekacin, gentamicin, sisomicin, netilmicin...  
WO/2019/242642A1
Provided are a pharmaceutically acceptable salt and crystal form of an OTR inhibitor and a preparation method thereof. In particular, provided are a pharmaceutically acceptable salt and crystal form of an OTR inhibitor 5-(3-(3-(6-fluoron...  
WO/2019/242646A1
Provided are a polycrystal form of an oxytocin receptor (OTR) inhibitor compound 5-(3-(3-(6-fluoronaphthalen-1-yl)azetidin-1-yl)5-(methoxymet hyl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridine and a preparation method therefor. Relative to an...  
WO/2019/238893A1
The present invention concerns the use of an inhibitor of interleukin- (IL-1), in particular of IL-1αand/or IL-1β, for the prevention or treatment of chronic histiocytic intervillositis (CHI) or a symptom associated thereof, eventually...  
WO/2019/239268A1
A composition is described, comprising: lepidium meyenii walp; a pharmaceutically acceptable salt of manganese; vitamin E; a pharmaceutically acceptable salt of selenium and a pharmaceutically acceptable salt of zinc: alpha-lipoic acid, ...  
WO/2019/235455A1
The present invention addresses the problem of providing: an enhancer of the fertilization function of a mammal sperm, which contains a low-molecular-weight compound that can be produced in a relatively simple manner and at relatively lo...  
WO/2019/235451A1
Provided is a composition for treating menstrual symptoms, which contains α-lactalbumin. In addition, the present invention provides: a non-medical method for treating menstrual symptoms comprising a step of having a subject ingest a co...  
WO/2019/227122A1
A method of enhancing embryo implantation in a subject is disclosed which comprises administering to the uterine cavity of the subject a formulation comprising copper and/or zinc in an amount effective to stimulate endometrial production...  
WO/2019/226755A1
The present invention relates to amino acid salts of nicotinic acid ribosides and compositions thereof of Formula I, useful in the treatment of disorders and diseases associated with deficiencies in NAD+: wherein M1, R1, R2, and R3 are a...  
WO/2019/223218A1
A traditional Chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast, comprising an adhesive layer, an energy layer, a magnetized layer, a medicinal film layer, and a ...  
WO/2019/221531A1
The present invention relates to a composition for improving the vaginal health of women comprising poly-gamma-glutamic acid or a salt thereof. More specifically, the present invention provides a composition for improving the vaginal hea...  

Matches 701 - 750 out of 27,402